Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC)

NCT06015503

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Guangdong General Hospital Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

NCT03786692

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC

NCT03527108

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: NYU Langone New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

NCT06238479

Conditions: Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations: AdventHealth Orlando Orlando, Florida, United States

Emory University Atlanta, Georgia, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Washington University School of Medicine St Louis, Missouri, United States

View all 28 locations

View Trial Details

Active, Not Recruiting

Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule.

NCT05817110

Conditions: Lung Diseases, Lung Malignancy, Lung Neoplasms, +5 more
Locations: Research Site Alexandria, Egypt

Research Site Cairo, Egypt

Research Site Gurugram, Haryana, India

Research Site New Delhi, National Capital Territory of Delhi, India

View all 22 locations

View Trial Details

Active, Not Recruiting

SCOOT: Sample Collection for DART

NCT05368298

Conditions: Disease, Lung Cancer, Lung Diseases, +8 more
Locations: Lung Health Check: Oxford - Churchill Hospital, OUH Oxford, Oxfordshire, United Kingdom

Lung Health Check Centre: Royal Sussex Brighton, United Kingdom

Lung Health Check Centre: North Bristol Bristol, United Kingdom

Lung Health Check Centre: Gateshead Gateshead, United Kingdom

View Trial Details

Active, Not Recruiting

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

NCT06564844

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations: Research Site Tucson, Arizona, United States

Research Site Duarte, California, United States

Research Site Glendale, California, United States

Research Site Los Angeles, California, United States

View all 90 locations

View Trial Details

Active, Not Recruiting

MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)

NCT04841811

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Guangdong Lung cancer institute Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

NCT04015778

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

NCT02696993

Conditions: Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Respiratory Tract Neoplasms

Respiratory Tract Neoplasms trial results

Related conditions